Photo from academic.microsoft.com
Highlights • Benzyl salicylate (BS) is on priority lists for evaluation of estrogenic effects.• New data in both MCF7 (E-screen) and luciferase transactivation assays.• Potency of BS is 21′000′000-fold lower… Click to show full abstract
Highlights • Benzyl salicylate (BS) is on priority lists for evaluation of estrogenic effects.• New data in both MCF7 (E-screen) and luciferase transactivation assays.• Potency of BS is 21′000′000-fold lower than estradiol in transactivation assay.• Potency of BS is 36′000′000-fold lower than estradiol in E-screen.• Potency is > 1000-fold below human relevant potency threshold.
Keywords:
benzyl salicylate;
potency;
estrogenic potency;
potency benzyl;
assessment estrogenic;
critical assessment
Journal Title: Toxicology Reports
Year Published: 2021
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Toxicology Reports
Year Published: 2021
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!